This Article Full Text (PDF) All Versions of this Article: 1538574408322755v1 42/6/517    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Birk, D. M. Articles by Chaer, R. A. Search for Related Content PubMed PubMed Citation Articles by Birk, D. M. Articles by Chaer, R. A. Social Bookmarking                         What's this?

Basic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation

College of Physicians and Surgeons, Columbia University, New York

Joel Barbato, MD

College of Physicians and Surgeons, Columbia University, New York

Leila Mureebe, MD

College of Physicians and Surgeons, Columbia University, New York

Rabih A. Chaer, MD

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, chaerra{at}upmc.edu

Vascular endothelial growth factor (VEGF) is a key molecule that orchestrates the formation and function of vascular networks. Impaired regulation of angiogenesis is implicated in a number of pathologic states. For instance, neoplasias exhibit uncontrolled angiogenesis, whereas ischemia and states of vascular insufficiency involve reduced VEGF activity. As the role of VEGF has been elucidated in these disease processes, its therapeutic role has been developed. The Food and Drug Administration has approved several anti-VEGF agents for treating colorectal, lung, and kidney cancer. VEGF-inducing agents have also been used experimentally to induce angiogenesis in patients with critical limb ischemia. As more knowledge is gathered about the biology of VEGF and its receptors, there is greater promise for therapeutic modulation of VEGF expression. The purpose of this review is to describe the various therapeutic and biologic factors that regulate the expression of VEGF.

Key Words: vascular endothelial growth factor • peripheral vascular disease • coronary artery disease

This version was published on January 1, 2009

Vascular and Endovascular Surgery, Vol. 42, No. 6, 517-530 (2009)
DOI: 10.1177/1538574408322755


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?